4//SEC Filing
Chrousos Phaedra 4
Accession 0001209191-22-038446
CIK 0001347178other
Filed
Jun 20, 8:00 PM ET
Accepted
Jun 21, 4:53 PM ET
Size
7.3 KB
Accession
0001209191-22-038446
Insider Transaction Report
Form 4
Chrousos Phaedra
Director
Transactions
- Award
Common Stock
2022-06-16+12,006→ 24,931 total - Award
Stock Option (Right to Buy)
2022-06-16+24,707→ 24,707 totalExercise: $9.37Exp: 2032-06-15→ Common Stock (24,707 underlying)
Footnotes (2)
- [F1]Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on June 16, 2023, provided that the Reporting Person has provided continuous service to the Issuer through the vesting date.
- [F2]This option vests and becomes exercisable with respect to 100% of the option shares on June 16, 2023, provided that the Reporting Person has provided continuous service to the Issuer through the vesting date.
Documents
Issuer
Vanda Pharmaceuticals Inc.
CIK 0001347178
Entity typeother
Related Parties
1- filerCIK 0001774518
Filing Metadata
- Form type
- 4
- Filed
- Jun 20, 8:00 PM ET
- Accepted
- Jun 21, 4:53 PM ET
- Size
- 7.3 KB